Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

80%

4 of 5 completed trials have results

Key Signals

4 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT03573206Not ApplicableCompleted

AMBULATE Continued Access Protocol to Evaluate the Cardiva Mid-Bore Venous Vascular Closure System (VVCS)

Role: lead

NCT03193021Not ApplicableCompleted

AMBULATE: Cardiva Mid-Bore VVCS vs. Manual Compression for Multiple Femoral Venous Access Sites, 6 - 12F ID

Role: lead

NCT04203329Unknown

AMBULATE Same Day Discharge Registry

Role: lead

NCT04538781Completed

AMBULATE VASCADE MVP Same Day Discharge Retrospective Registry

Role: lead

NCT01297322Not ApplicableCompleted

RESPECT Trial - (Rapid Extravascular Sealing Via PercutanEous Collagen ImplanT)

Role: lead

NCT02948257Completed

VASCADE ANTEGRADE-PVD Post-Market Registry

Role: lead

All 6 trials loaded